How you can plan ahead to prevent seasonal spring allergy symptoms
Spring officially starts March 20, but we're already in allergy season. Let's talk about the signs, symptoms, treatments, and ...
Health Beat: Preparing for spring allergies
Experts say it's important to prepare for seasonal allergies now to lessen, and perhaps even prevent, symptoms.
Hosted on MSN2d
Prepare now for spring allergies
Start taking your nasal steroid spray a week or two before spring allergy season begins. Ontario's Ford suspends U.S.
Spend $50 on allergy items at Amazon and get $10 off your order — just in time for spring pollen
Until March 24 at 11:59 p.m. PT, spend $50 or more on eligible allergy products at Amazon to get $10 off your purchase. To score this deal, add $50 worth of product to your Amazon cart and the ...
Dermatology Advisor3d
Neffy 1 mg Approved to Treat Severe Allergic Reactions in Younger Children
Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions in children aged 4 ...
Rolling Out3d
Medical alert for throat pain beyond allergies
Discover the key differences between allergy-related throat pain and more concerning conditions with expert-backed indicators ...
California biotech company gets FDA approval for EpiPen alternative for kids
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)
Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...
Is it allergies or a sinus infection? Here’s a telltale sign
One of the telltale signs to discern if you have allergic rhinitis or a sinus infection is if you have itchy, watery eyes ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent
Altamira Therapeutics Ltd. (OTCQB:CYTOF) today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for a patent (application #17/466,142) relating to the ...
San Diego biotech gets FDA approval for EpiPen alternative for kids
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...